: Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma. Blood 2011, 118:4919–4929.PubMedCrossRef 8. Nakashima Y, Tagawa H, Suzuki R, Karnan S, Karube K, Ohshima K, Muta K, Nawata H, Morishima Y, Nakamura

selleck compound S, Seto M: Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type. Gene Chromosome Canc 2005, 44:247–255.CrossRef 9. Ko YH, Choi KE, Han JH, Kim JM, Ree HJ: Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma. Cytometry 2001, 46:85–91.PubMedCrossRef 10. Yoon J, Ko YH: Deletion mapping of the long arm of chromosome 6 in peripheral T and NK cell lymphomas. Leuk Lymphoma 2003, 44:2077–2082.PubMedCrossRef 11. Iqbal J, Kucuk C, Deleeuw RJ, Srivastava G, Tam W, Geng H, Klinkebiel D, Christman JK, Patel K, Cao K, selleckchem et al.: Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 2009, 23:1139–1151.PubMedCrossRef 12. Kucuk C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivastava G, Au WY, McKeithan TW, Chan WC: PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci U S A 2011, 108:20119–20124.PubMedCentralPubMedCrossRef 13. Karube K,

Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, Shimizu N, Ko YH, Morishima Y, Ohshima K, et al.: Identification of FOXO3 and PRDM1 as tumor-suppressor

gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011, 118:3195–3204.PubMedCrossRef 14. Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh SC, et al.: Extranodal NK/T-cell lymphoma, nasal type. In World Health Organization classification of tumors. WHO classification of tumours of aematopoietic and lymphoid tissues. Edited by: Swerdlow SH. Lyon, France: IARC Press; 2008:285–288. 15. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, Takigawa M, Sasaki M, Minato N, Tsudo M, et al.: TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 1985, 134:1623–1630.PubMed 16. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J: Characterization Pembrolizumab in vivo of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996, 24:406–415.PubMed 17. Gong JH, Maki G, Klingemann HG: Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of check details activated natural killer cells. Leukemia 1994, 8:652–658.PubMed 18. Garcia JF, Roncador G, Sanz AI, Maestre L, Lucas E, Montes-Moreno S, Fernandez Victoria R, Martinez-Torrecuadrara JL, Marafioti T, Mason DY, Piris MA: PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica 2006, 91:467–474.PubMed 19.